by Benzinga Insights | Sep 23, 2026 | General
Glaukos (NYSE:GKOS) has outperformed the market over the past 10 years by 1.4% on an annualized basis producing an average annual return of 14.97%. Currently, Glaukos has a market capitalization of $9.57 billion. Buying $1000 In GKOS: If an investor had bought $1000...
by Benzinga Insights | Sep 23, 2026 | General
Cintas (NASDAQ:CTAS) reported first-quarter financial results on Wednesday. The transcript from the company’s first-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit...
by Surbhi Jain | Sep 23, 2026 | General
Elon Musk has two companies betting billions on futuristic technologies, but Fitch Ratings is putting more credit behind one than the other. The ratings agency gave Tesla, Inc. (NASDAQ:TSLA) a BBB rating with a stable outlook. Space Exploration Technologies Corp....
by Benzinga Insights | Sep 23, 2026 | General
Paychex (NASDAQ:PAYX) reported first-quarter financial results on Wednesday. The transcript from the company’s first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog,...
by Vandana Singh | Sep 23, 2026 | General
AC Immune SA (NASDAQ:ACIU) on Wednesday shared week-100 safety and immunogenicity results from Part 1 of its Phase 2 VacSYn clinical trial evaluating ACI-7104 in patients with early-stage Parkinson’s disease. “We will now refine our approach to the next development...
Recent Comments